Cargando…
Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapy
5-fluorouracil (5-FU) is the first line component used in colorectal cancer (CRC) therapy however even in combination with other chemotherapeutic drugs recurrence is common. Mutations of the adenomatous polyposis coli (APC) gene are considered as the initiating step of transformation in familial and...
Autores principales: | Martino-Echarri, Estefania, Henderson, Beric R., Brocardo, Mariana G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259445/ https://www.ncbi.nlm.nih.gov/pubmed/25301724 |
Ejemplares similares
-
Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta
por: Martino-Echarri, Estefania, et al.
Publicado: (2016) -
Rac1 augments Wnt signaling by stimulating β-catenin–lymphoid enhancer factor-1 complex assembly independent of β-catenin nuclear import
por: Jamieson, Cara, et al.
Publicado: (2015) -
APC binds the Miro/Milton motor complex to stimulate transport of mitochondria to the plasma membrane
por: Mills, Kate M., et al.
Publicado: (2016) -
Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing
por: Feijoo, Carmen, et al.
Publicado: (2001) -
The utility of Apc-mutant rats in modeling human colon cancer
por: Irving, Amy A., et al.
Publicado: (2014)